Skip to main content
Top

01-11-2019 | Psoriatic arthritis | ACR/ARP 2019 | Article

Researcher comment: The DISCOVER-2 trial

print
PRINT
insite
SEARCH

Lead investigator Philip Mease outlines the results of the DISCOVER-2 trial, and discusses how guselkumab may impact the psoriatic arthritis treatment landscape (8:26).

Transcript

Back to the ACR/ARP 2019 conference hub

print
PRINT